CardioMEMS-Guided CAR T Cell Therapy for Lymphoma in a Patient With Anthracycline-Induced Cardiomyopathy

Kanelidis, A. J., Raikhelkar, J., Kim, G., Sayer, G., Bishop, M. R., Polonsky, T. S., & Uriel, N. (2020). CardioMEMS-Guided CAR T Cell Therapy for Lymphoma in a Patient With Anthracycline-Induced Cardiomyopathy. JACC: CardioOncology, 2(3), 515–518. https://doi.org/10.1016/j.jaccao.2020.06.005
Authors:
Anthony J Kanelidis
Jayant Raikhelkar
Gene Kim
Gabriel Sayer
Michael R Bishop
Tamar S Polonsky
Nir Uriel
Affiliated Authors:
Jayant Raikhelkar
Gabriel Sayer
Nir Uriel
Columbia Affiliation:
Author Keywords:
car, chimeric antigen receptor
crs, cytokine release syndrome
dlbcl, diffuse large b-cell lymphoma
gdmt, guideline-directed medical therapy
hf, heart failure
lvef, left ventricular ejection fraction
pad, pulmonary artery diastolic pressure
r-chop, rituximab, cyclophosphamide, doxorubicin, vincristine, prednisone
rhc, right heart catherization
tte, transthoracic echocardiogram
anthracycline
cardiomyopathy
heart failure
immunotherapy
lymphoma
elink
Publication Type:
Article
Unique ID:
10.1016/j.jaccao.2020.06.005
PMID:
34396261
DOI:
10.1016/j.jaccao.2020.06.005
Journal:
JACC: CardioOncology
Publication Date:
Data Source:
PubMed
Source Link:
View PubMed Record

Record Created: